Jenoptik Expands Presence in Asia

Jenoptik's Lasers + Material Processing division will in future be represented in the Asian market with a laser application center, in close cooperation with the Korean company Telstar-Hommel Corp.. Byung-Hoon Im, President and CEO of Telstar-Hommel, and Michael Mertin, CEO of JENOPTIK AG, signed the shareholders agreement for JENOPTIK Korea Corp., on July 2nd. Telstar-Hommel will hold 33.3 percent of shares in the company which is headquartered in Pyeongtaek (Gyeonggi Province). With 66.6 percent, JENOPTIK AG will be the majority shareholder.

With the joint company, Jenoptik is boosting its direct presence in Asia. By the beginning of next year, an application center for Asian customers of the Lasers & Material Processing division will be built locally. The partners will invest a total of 4.4 million US dollars.

The application center is aimed at the entire Asian market and is due to open in early 2010. Jenoptik will present a range of systems for laser material processing there, specifically addressing the electronics, flat-panel, and photovoltaics industries. Jenoptik laser processing systems will then be available to interested parties for processing brittle materials such as display glass, solar cells, ceramics and silicon wafers, as well as for the special laser separation method for these materials, so-called TLS-dicing (TLS = thermal laser separation). Customers may test production techniques on the systems and refine them in accordance with their requirements.

The optoelectronics group Jenoptik divides its activities into the five divisions Lasers & Material Processing, Optical Systems, Industrial Metrology, Traffic Solutions and Defense & Civil Systems. Its customers mainly include companies in the semiconductor and semiconductor equipment manufacturing industry, automotive and automotive supplier industry, medical technology, security and defense technology as well as the aerospace industry.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.